Migraine Insights: AI-Enhanced Learning for Diagnosis, Treatment, and Equity

Statement of Need 

Primary care providers (PCPs) frequently struggle with accurate migraine diagnosis, resulting in significant rates of misdiagnosis and underdiagnosis. Despite migraine affecting millions of Americans, it continues to be underdiagnosed and undertreated in primary care settings. This diagnostic challenge is particularly concerning as most migraine patients first seek treatment from PCPs. 
Significant disparities exist in migraine diagnosis and treatment among racial and ethnic minority groups. People from African American, Latino, and American Indian and Alaska Native backgrounds are vastly underrecognized, underdiagnosed, and undertreated for migraine compared to their White counterparts. 

After participating in this education, learners will be able to: 

• Utilize validated screening tools to accurately diagnose migraine in primary care settings. 

• Recognize the prevalence and impact of migraine in women across different life stages. 

• Apply gender- and reproductive-health considerations in migraine management 

• Identify and mitigate racial, ethnic, and socioeconomic disparities in migraine diagnosis, treatment, and outcomes 

• Utilize telehealth and other innovative approaches to enhance access to migraine care for underserved communities 

• Define and distinguish between resistant and refractory migraine based on current clinical criteria. 

• Evaluate the efficacy of various pharmacologic options for resistant and refractory migraine. 

Nursing Credit 

Medical Education Resources designates this enduring material for a maximum of 1.0 ANCC nursing contact hours. Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299. 

Physician Associates Credit 

Medical Education Resources has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

Financial Disclosures 

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company. 

Annika Ehrlich, DNP, FNP-C, CNRN, AQH 
Advisory Board: Abbvie, Pfizer, Lundbeck 
Consultant: Abbvie, PharmaMark 
Speaker: Abbvie 

Jordan Mast, PA-C 
Consultant: Abbvie, Eisai, Pfizer, Eli Lilly 
Speaker: Abbvie, Axsome, Eisai, Eli Lilly 

The content managers reported the following financial relationships with ineligible companies whose products or services may be mentioned in this activity: